Showing 2561-2570 of 2784 results for "".
- Industry Responds to COVID-19: Epionce, E.T. Browne Drug Co., RealSelf, HydraFacial, Thrive Causemeticshttps://modernaesthetics.com/news/industry-responds-to-covid-19-et-browne-drug-co-realself-hydrafacial-thrive-causemetics-1/2472911/Epionce. Epionce has added to its existing Shop Epionce program by rolling out a Direct Ship program. Through the Shop Epionce program, offices receive a personalized hyperlink and code that patients can shop with on Epionce.
- Industry Responds to COVID-19: PCA Skin, Henry Schein Medicalhttps://modernaesthetics.com/news/industry-responds-to-covid-19-pca-skin-henry-schein-medical/2472910/PCA Skin. PCA Skin®is partnering with FABRIC and its non-profit AZ Apparel Foundation that is using their resources to produce FDA-approved Personal Protective Equipment (PPE) during the COVID-19 health emergency. From April 13 to 30, PCA Skin will donate
- Facial Plastic Surgeons Respond to COVID-19, Part II: Taking Care of Patients and Staffhttps://modernaesthetics.com/news/part-ii-facial-plastic-surgeons-respond-to-covid-19-taking-care-of-patients-and-staff/2472909/With calls to cancel all elective procedures and widespread stay-at-home orders in place, COVID-19 has dramatically upended the practice of facial plastic surgery in the US and abroad. Here, two American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) board members di
- Industry Responds to COVID-19: E.T. Browne Drug Co., RealSelf, HydraFacial, Thrive Causemeticshttps://modernaesthetics.com/news/industry-responds-to-covid-19-dermyoung-coty-leo-pharma/2472903/E.T. Browne Drug Co. The manufacturer of Palmer' Cocoa Butter Formula and Coconut Oil Formula skin and hair care products is now producing medical-grade hand sanitizer to address widespread supply shortages in the wake of COVID-19. Initial production of the disinfectant sanit
- Facial Plastic Surgeons Respond to COVID-19: “We Will Get Through This...Whatever It Takes”https://modernaesthetics.com/news/facial-plastic-surgeons-respond-to-covid-19-we-will-get-through-thiswhatever-it-takes/2472902/All health care professionals are doing what they can to help Americans cope with the COVID-19 pandemic. For facial plastic surgeons, COVID-19 has caused an upheaval in their professional lives with office closures and the postponement of all elective procedures. The CARES Act is h
- Survey Explores Negative Impact of COVID-9, Economic Fallout on Jobshttps://modernaesthetics.com/news/survey-explores-negative-impact-of-covid-9-economic-fallout-on-jobs/2472899/While 35 percent of 1,000 Americans surveyed by LendEDU say that that their jobs have not been impacted by the Coronavirus, six percent report losing their job, 13 percent report that hours have been partially cut, and 11 percent have had hours cut entirely, though they still have their jobs.
- Lumenis Launches Stellar M22 Platformhttps://modernaesthetics.com/news/lumenis-launches-stellar-m22-platform/2472890/Lumenis Ltd. is launching the Stellar M22, a multi-application platform that builds on the heritage of the M22 by adding even more bells and whistles. The new Stellar M22 is now available in the USA and Europe. "Lu
- FDA Sets November PDUFA Date for DaxibotulinumtoxinA from Revancehttps://modernaesthetics.com/news/fda-sets-november-pdufa-date-for-daxibotulinumtoxina-from-revance/2472880/FDA has accepted the Biologics License Application (BLA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar (frown) lines, Revance reports. The FDA set an action date of November 25, 2020 under the Prescription Drug User Fee Act (PDUFA) VI program.
- Candela Launches Exceed Medical Microneedling Systemhttps://modernaesthetics.com/news/candela-launches-exceed-medical-microneedling-system/2472878/Candela Corporation has entered into an exclusive collaboration agreement with MT.DERM GmbH for the commercialization of MT.DERM's medical microneedling products. Under the terms of the agreement, Candela will commercialize the Exceed medical microneedling system globally, with a first launch
- Cynosure News: Todd Tillemans Named New CEOhttps://modernaesthetics.com/news/cynosure-news-todd-tillemans-named-new-ceo/2472869/Todd Tillemans is the new Chief Executive Officer of Cynosure, LLC. Mr. Tillemans is the former President of Hershey's flagship U.S. business generating more than $6.5 billion in annual sales. Prior to that, he held various leadership positions across Unilever's